Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influenza A (H1N1) Challenge Study
NCT02746211Phase 2Completed
- Sponsor
- hVIVO
- Start
- Jan 2008
- Primary completion
- Dec 2008
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in influenza (4 arms), sponsored by hVIVO. Primary endpoint: The infection rate of an Influenza (A/New Caledonia/20/99) virus at 14 days. Started Jan 2008; status: completed.
02
Conditions
influenza
Beyond the preview
Go deeper on NCT02746211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02746211.